Trichobiolight: A new, effective protocol in the treatment of androgenetic alopecia and telogen effluvium

    February 2021 in “Dermatologic Therapy
    Domenico Piccolo, Giuliana Crisman, Claudio Conforti, Marta Buzzi, C. Genovesi, Daniela Elisa Marchi, Mazzaracchio D, Mohamad Goldust
    Image of study
    TLDR Trichobiolight effectively treats hair loss with 82.5% success.
    Trichobiolight is a new treatment protocol that combines mesotherapy and LED light to treat hair loss diseases such as androgenetic alopecia and telogen effluvium. A study with 107 patients showed that it was effective in treating these conditions, with 82.5% of patients having excellent to good outcomes. Trichobiolight is a non-invasive treatment that uses light therapy to stimulate hair growth and improve scalp health. It has shown promising results in clinical studies for androgenetic alopecia and telogen effluvium.
    View this study on onlinelibrary.wiley.com →

    Cited in this study

    Related

      Hair disorders

      research Hair disorders

        August 2018 in “Oxford University Press eBooks”
      The document's conclusion cannot be provided because the document cannot be parsed.
      Frontal fibrosing alopecia

      research Frontal fibrosing alopecia

      6 citations ,   July 2017 in “British Journal of Dermatology”
      Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.
      HAIR DISEASES

      research HAIR DISEASES

      28 citations ,   September 1998 in “Medical Clinics of North America”
      Most hair loss can be diagnosed with patient history and physical exam, and a few common types make up most cases.